MedPath

Pentixapharm AG

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

[90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients

Phase 1
Recruiting
Conditions
CNS Lymphoma
Interventions
First Posted Date
2023-11-15
Last Posted Date
2025-01-13
Lead Sponsor
Pentixapharm AG
Target Recruit Count
15
Registration Number
NCT06132737
Locations
🇩🇪

University Hospital Rechts der Isar, Munich, Bavaria, Germany

🇩🇪

University Hospital Essen, Essen, Germany

[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma

Phase 3
Recruiting
Conditions
Marginal Zone Lymphoma
Interventions
Drug: [18F]Fluorodeoxyglucose
First Posted Date
2023-11-09
Last Posted Date
2025-02-26
Lead Sponsor
Pentixapharm AG
Target Recruit Count
148
Registration Number
NCT06125028
Locations
🇦🇹

Medizinische Universität Innsbruck, Innsbruck, Austria

🇫🇷

CHU de Bordeaux, Bordeaux, France

🇫🇷

CHU La Timone, Marseille, France

and more 9 locations

[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients

Phase 2
Terminated
Conditions
CNS Lymphoma
Interventions
First Posted Date
2022-02-03
Last Posted Date
2024-12-02
Lead Sponsor
Pentixapharm AG
Target Recruit Count
1
Registration Number
NCT05222269
Locations
🇫🇷

University Hospital CHU Nantes, Nantes, France

🇩🇰

University Hospital Aalborg, Aalborg, Denmark

© Copyright 2025. All Rights Reserved by MedPath